Suplatast (Tosilate) T0117
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Suplatast Tosilate is a novel capsular anti-asthmatic drug. It ( IC50 above 100 _M) inhibits both IgE production, IL-4 and IL-5 synthesis.
CAS nr:
94055-76-2
Purity:
98%
Molecular Weight:
499,64
SMILES:
CCOCC(COc1ccc(cc1)NC(=O)CC[S+](C)C)O.Cc1ccc(cc1)S(=O)(=O)[O-]
Formula:
C23H33NO7S2
Pathway:
Immunology/Inflammation,Immunology/Inflammation
Target:
Interleukin,IL Receptor
